News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
302,615 Results
Type
Article (16420)
Company Profile (113)
Press Release (286074)
Multimedia
Podcasts (80)
Webinars (13)
Section
Business (95831)
Career Advice (471)
Deals (16850)
Drug Delivery (82)
Drug Development (39447)
Employer Resources (51)
FDA (6990)
Job Trends (6626)
News (163222)
Policy (15601)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (576)
Accelerated approval (13)
Adcomms (9)
Allergies (73)
Alliances (25596)
ALS (63)
Alzheimer's disease (531)
Antibody-drug conjugate (ADC) (162)
Approvals (7251)
Artificial intelligence (219)
Autoimmune disease (55)
Automation (12)
Bankruptcy (152)
Best Places to Work (4675)
BIOSECURE Act (21)
Biosimilars (125)
Biotechnology (46)
Bladder cancer (43)
Brain cancer (31)
Breast cancer (214)
Cancer (1752)
Cardiovascular disease (172)
Career advice (424)
Career pathing (13)
CAR-T (96)
CDC (6)
Cell therapy (232)
Cervical cancer (18)
Clinical research (34510)
Collaboration (836)
Compensation (329)
Complete response letters (35)
COVID-19 (1083)
CRISPR (45)
C-suite (447)
Cystic fibrosis (65)
Data (2225)
Denatured (20)
Depression (48)
Diabetes (153)
Diagnostics (1727)
Digital health (11)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (124)
Drug pricing (116)
Drug shortages (13)
Duchenne muscular dystrophy (86)
Earnings (37185)
Editorial (25)
Employer branding (4)
Employer resources (46)
Events (42379)
Executive appointments (545)
FDA (8295)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (474)
Gene editing (82)
Generative AI (20)
Gene therapy (186)
GLP-1 (497)
Government (1653)
Grass and pollen (4)
Guidances (196)
Healthcare (4318)
HIV (12)
Huntington's disease (11)
IgA nephropathy (49)
Immunology and inflammation (81)
Immuno-oncology (22)
Indications (57)
Infectious disease (1154)
Inflammatory bowel disease (82)
Inflation Reduction Act (7)
Influenza (26)
Intellectual property (131)
Interviews (61)
IPO (6614)
IRA (33)
Job creations (2146)
Job search strategy (379)
JPM (36)
Kidney cancer (11)
Labor market (33)
Layoffs (235)
Leadership (8)
Legal (3721)
Liver cancer (31)
Longevity (8)
Lung cancer (301)
Lymphoma (157)
Machine learning (13)
Management (18)
Manufacturing (454)
MASH (77)
Medical device (2120)
Medtech (2130)
Mergers & acquisitions (10686)
Metabolic disorders (513)
Multiple sclerosis (50)
NASH (16)
Neurodegenerative disease (94)
Neuropsychiatric disorders (41)
Neuroscience (976)
Neurotech (1)
NextGen: Class of 2026 (1733)
Non-profit (693)
Now hiring (17)
Obesity (268)
Opinion (152)
Ovarian cancer (45)
Pain (113)
Pancreatic cancer (59)
Parkinson's disease (88)
Partnered (13)
Patents (259)
Patient recruitment (164)
Peanut (12)
People (30990)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase 1 (9222)
Phase 2 (14496)
Phase 3 (13103)
Pipeline (2235)
Policy (163)
Postmarket research (1430)
Preclinical (3552)
Press Release (59)
Prostate cancer (88)
Psychedelics (17)
Radiopharmaceuticals (144)
Rare diseases (383)
Real estate (3067)
Recruiting (18)
Regulatory (12225)
Reports (18)
Research institute (663)
Resumes & cover letters (55)
Rett syndrome (5)
RNA editing (6)
RSV (21)
Schizophrenia (73)
Series A (94)
Series B (57)
Service/supplier (2)
Sickle cell disease (48)
Special edition (12)
Spinal muscular atrophy (83)
Sponsored (13)
Startups (1768)
State (2)
Stomach cancer (8)
Supply chain (53)
Tariffs (73)
The Weekly (58)
Vaccines (284)
Venture capital (38)
Weight loss (163)
Women's health (28)
Worklife (4)
Date
Last 7 days (209)
Last 30 days (816)
Last 365 days (11846)
2026 (1105)
2025 (12131)
2024 (14087)
2023 (15991)
2022 (22928)
2021 (23265)
2020 (21980)
2019 (16506)
2018 (13046)
2017 (15160)
2016 (14426)
2015 (16873)
2014 (13429)
2013 (11554)
2012 (12417)
2011 (12953)
2010 (11622)
Location
Africa (347)
Alabama (20)
Alaska (1)
Arizona (80)
Arkansas (3)
Asia (31025)
Australia (2932)
California (3637)
Canada (1557)
China (1124)
Colorado (144)
Connecticut (135)
Delaware (131)
Europe (44366)
Florida (652)
Georgia (78)
Hawaii (1)
Idaho (12)
Illinois (362)
India (48)
Indiana (245)
Iowa (4)
Japan (296)
Kansas (78)
Kentucky (20)
Louisiana (6)
Maine (4)
Maryland (504)
Massachusetts (2902)
Michigan (59)
Minnesota (170)
Mississippi (1)
Missouri (41)
Montana (8)
Nebraska (7)
Nevada (20)
New Hampshire (12)
New Jersey (1569)
New Mexico (7)
New York (1035)
North Carolina (660)
North Dakota (2)
Northern California (1662)
Ohio (81)
Oklahoma (6)
Oregon (18)
Pennsylvania (783)
Puerto Rico (12)
Rhode Island (17)
South America (555)
South Carolina (13)
Southern California (1609)
Tennessee (53)
Texas (518)
United States (14143)
Utah (63)
Virginia (161)
Washington D.C. (46)
Washington State (235)
West Virginia (1)
Wisconsin (38)
Wyoming (1)
302,615 Results for "china pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
China
Clinical Trials Are Increasingly Going Global—With China a Main Beneficiary
AstraZeneca’s $15 billion pledge to its China operations highlights the country’s advantages. But other regions are also hoping to host more clinical studies.
February 2, 2026
·
8 min read
·
Annalee Armstrong
Insights
CRO Boom in APAC Region, With China at the Forefront
The CRO market in the APAC region is thriving, particularly in China, due to intense clinical trial and innovation development, with Western investors and pharma leaning in.
November 19, 2025
·
5 min read
·
Jennifer Smith-Parker
Press Releases
China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering
January 12, 2026
·
3 min read
Press Releases
Arrowhead Pharmaceuticals Announces NMPA Approval of REDEMPLO® (plozasiran) for Familial Chylomicronemia Syndrome (FCS) in China
January 7, 2026
·
7 min read
Press Releases
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN
January 16, 2026
·
3 min read
Press Releases
2026 China FIC Innovation and Collaboration Summit Held in San Francisco, Chinese Pharmaceutical Companies Showcase Innovative Achievements
January 19, 2026
·
7 min read
Antibody-drug conjugate (ADC)
Roche Inks Another China ADC Pact With $1.5B Hansoh Bet
Roche will gain worldwide rights outside of the Greater China region to Hansoh’s HS-20110, an antibody-drug conjugate in early-stage development for colorectal cancer.
October 17, 2025
·
2 min read
·
Tristan Manalac
Funding
China’s Corxel Nabs $287M Series D1 to Bankroll GLP-1 Pill
Corxel will use the fundraising proceeds to advance the oral GLP-1 therapy CX11 through mid-stage development in the U.S., as well as prepare for its Phase III studies.
January 23, 2026
·
1 min read
·
Tristan Manalac
Alzheimer’s disease
Novartis Makes $1.5B+ Alzheimer’s Play With China’s SciNeuro
The deal will see Novartis gain global rights over SciNeuro’s potentially disease-modifying anti-amyloid antibody, which leverages the latter’s proprietary shuttle platform to allow delivery into the brain.
January 12, 2026
·
2 min read
·
Tristan Manalac
Lung cancer
Roche Spends $570M on Another ADC Agreement With China’s MediLink
Roche first partnered with MediLink in January 2024, likewise for an antibody-drug conjugate for solid tumors.
January 9, 2026
·
1 min read
·
Tristan Manalac
1 of 30,262
Next
